Clinical Trial Update: Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining the combination of radiotherapy and thymosin in metastatic non-small cell lung cancer patients who had stable disease af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Thymosin (thymosin alpha-1)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Lung Adenocarcinoma | Phase 2 | Status: UNKNOWN